Two Northwestern Medicine investigators were among five Northwestern University faculty recently awarded the prestigious Presidential Early Career Award for Scientists and Engineers.
Northwestern Medicine scientists have developed and validated a tool to predict which patients with pre-osteoarthritis are at high risk for developing disability in the future.
Northwestern Medicine scientists have discovered that the protein FMRP — the loss of which leads to Fragile X syndrome — is a novel reader of RNA methylation.
The National Institutes of Health has awarded Northwestern University a five-year, $46 million grant to renew the Northwestern University Clinical and Translational Sciences Institute.
An emerging class of cancer drugs has shown promise in treating pancreatic cancer, but the drugs may cause severe liver damage when combined with high-fat diets, according to study published in PNAS.
Jordan Sell, a rising third-year student, has taken advantage of the wide range of opportunities at Feinberg.
A new Northwestern Medicine study published in PLOS One affirmed the importance of monitoring patients with age-related macular degeneration to ensure their disease does not progress further.
A new study published in JAMA found neladenoson bialanate did not improve exercise capacity among patients suffering from heart failure with preserved ejection fraction.
A drug called tanezumab reduced pain and improved physical function in patients with osteoarthritis, although more research on safety is needed, according to a study published in JAMA.
Daily vitamin D supplements did not significantly reduce the risk of Type 2 diabetes among adults at high risk for the disease, according to a large clinical trial published in The New England Journal of Medicine.